Newsroom | 12312 results

Sorted by: Latest
Medical Supplies
-

AtriCure to Participate in the J.P. Morgan 44th Annual Healthcare Conference

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming J.P. Morgan 44th Annual Healthcare Conference. AtriCure’s management is scheduled to present on Wednesday, January 14, 2026, at 10:30 a.m. Pacific Standard Time. Interested parties may access a live aud...
-

Two of 18 CMS-Covered Skin Substitute Products are Medical-Fish-Skin Grafts from Kerecis

ARLINGTON, Va. & REYKJAVIK, Iceland--(BUSINESS WIRE)--CMS finalized skin substitute coverage cutting 340 products down to 18 products nationwide. Two are Kerecis fish-skin grafts, MariGen and Shield....
-

Commercial Dryer Market Outlook and Competition Benchmark 2025-2032 Featuring Alliance Laundry Systems, Electrolux Professional, Haier Smart Home Co., Dexter Laundry, Girbau and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Commercial Dryer Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The commercial dryer market is responding to evolving industry demands with advancements in efficiency, connectivity, and sustainability. Senior decision-makers must keep pace with this landscape as operational pressures, regulatory changes, and customer expectations drive ongoing transformation. Market Snapshot: Commercial Dryer Market Growth and Dynami...
-

Nippon Electric Glass va lancer la première production en série au monde de tubes en verre à faible teneur en carbone destinés à l’industrie pharmaceutique à l’aide d’un four entièrement électrique

OTSU, Japon--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG) (TOKYO : 5214), leader mondial dans le domaine du verre spécialisé dont le siège social est situé à Otsu, au Japon, a annoncé qu’il allait lancer la première production en série au monde de tubes en verre de qualité pharmaceutique à l’aide d’un four de fusion entièrement électrique. La production commerciale devrait démarrer en décembre 2025 dans sa filiale de Selangor, en Malaisie. Cette avancée majeure introduit un nouveau mo...
-

Samenvatting: Nippon Electric Glass start 's werelds eerste massaproductie van koolstofarme farmaceutische glazen buizen met behulp van een volledig elektrische oven

OTSU, Japan--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG) (TOKYO:5214), een wereldwijde leider op het gebied van speciaal glas met hoofdkantoor in Otsu, Japan, heeft aangekondigd dat het zal beginnen met 's werelds eerste massaproductie van farmaceutische glazen buizen met behulp van een volledig elektrische smeltoven. De commerciële productie gaat naar verwachting in december 2025 van start bij haar dochteronderneming in Selangor, Maleisië. Deze doorbraak introduceert een nieuw produ...
-

Riassunto: Nippon Electric Glass avvierà la prima produzione di massa al mondo di tubi di vetro farmaceutici a basso contenuto di carbonio utilizzando una fornace totalmente elettrica

OTSU, Giappone--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), un leader globale nella produzione di vetro per usi speciali con sede a Otsu, Giappone, ha annunciato che avvierà la prima produzione di massa di tubi in vetro di grado farmaceutico utilizzando una fornace totalmente elettrica. L'inizio della produzione commerciale è previsto per dicembre 2025 presso l'azienda controllata di Selangor, Malesia. L'innovazione introduce un nuovo modello produttivo per le confezioni...
-

Nippon Electric Glass beginnt mit der weltweit ersten Massenproduktion klimafreundlicher pharmazeutischer Glasröhren unter Verwendung eines vollelektrischen Ofens

OTSU, Japan--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG) (TOKYO:5214), ein weltweit führender Hersteller von Spezialglas mit Hauptsitz in Otsu, Japan, gab bekannt, dass es mit der weltweit ersten Massenproduktion von Glasröhren in pharmazeutischer Qualität unter Verwendung eines vollelektrischen Schmelzofens beginnen wird. Die kommerzielle Produktion soll im Dezember 2025 in der Tochtergesellschaft in Selangor, Malaysia, anlaufen. Dieser Durchbruch führt ein neues Fertigungsmodell fü...
-

Resumen: Nippon Electric Glass pondrá en marcha la primera producción en masa del mundo de tubos de vidrio farmacéutico con bajas emisiones de carbono con un horno totalmente eléctrico

OTSU, Japón--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), líder mundial en vidrio de especialidad con sede en Otsu (Japón), ha anunciado que dará inicio a la primera producción en masa del mundo de tubos de vidrio de grado farmacéutico con un horno de fusión totalmente eléctrico. Está previsto iniciar la producción comercial para diciembre de 2025 en su filial de Selangor, Malasia. Este avance introduce un modelo nuevo de fabricación de envases farmacéuticos. Al combinar...
-

Nippon Electric Glass to Start World’s First Mass Production of Low-Carbon Pharmaceutical Glass Tubing Using an All-Electric Furnace

OTSU, Japan--(BUSINESS WIRE)--Nippon Electric Glass Co., Ltd. (NEG)(TOKYO:5214), a global leader in specialty glass headquartered in Otsu, Japan, announced it will begin the world’s first mass production of pharmaceutical-grade glass tubing using an all-electric melting furnace. Commercial production is scheduled to start in December 2025 at its subsidiary in Selangor, Malaysia. This breakthrough introduces a new manufacturing model for pharmaceutical packaging. By combining NEG’s proprietary a...
-

Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology, from TPG, a leading global alternative asset management firm. “We are excited to accelerate our acquisition of OneOncology, which will advance our management services...